A detailed history of Met Life Investment Management, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 10,722 shares of ANIP stock, worth $606,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,722
Previous 10,722 -0.0%
Holding current value
$606,650
Previous $682,000 6.3%
% of portfolio
0.0%
Previous 0.0%

Shares

40 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$58.53 - $68.82 $178,282 - $209,625
3,046 Added 39.68%
10,722 $682,000
Q1 2024

May 14, 2024

BUY
$54.2 - $69.69 $416,039 - $534,940
7,676 New
7,676 $530,000
Q3 2023

May 09, 2024

BUY
$50.28 - $64.61 $47,766 - $61,379
950 Added 14.12%
7,676 $445,000
Q3 2023

Apr 29, 2024

BUY
$50.28 - $64.61 $47,766 - $61,379
950 Added 14.12%
7,676 $445,000
Q3 2023

Nov 14, 2023

BUY
$50.28 - $64.61 $47,766 - $61,379
950 Added 14.12%
7,676 $445,000
Q2 2023

Apr 29, 2024

BUY
$37.29 - $53.83 $250,812 - $362,060
6,726 New
6,726 $362,000
Q1 2023

May 09, 2024

BUY
$37.61 - $45.72 $252,964 - $307,512
6,726 New
6,726 $267 Million
Q1 2023

May 15, 2023

BUY
$37.61 - $45.72 $10,831 - $13,167
288 Added 4.47%
6,726 $267,000
Q4 2022

May 10, 2024

BUY
$31.9 - $41.95 $18,502 - $24,331
580 Added 9.9%
6,438 $259,000
Q4 2022

Jun 14, 2023

SELL
$31.9 - $41.95 $9,187 - $12,081
-288 Reduced 4.28%
6,438 $259,000
Q4 2022

Mar 22, 2023

BUY
$31.9 - $41.95 $18,502 - $24,331
580 Added 9.9%
6,438 $259,000
Q4 2022

Feb 15, 2023

BUY
$31.9 - $41.95 $18,502 - $24,331
580 Added 9.9%
6,438 $259,000
Q3 2022

Jun 14, 2023

SELL
$29.83 - $38.01 $25,892 - $32,992
-868 Reduced 12.91%
5,858 $188,000
Q2 2022

Jun 20, 2023

SELL
$23.09 - $33.46 $20,042 - $29,043
-868 Reduced 12.91%
5,858 $173,000
Q1 2022

May 10, 2024

BUY
$26.91 - $47.15 $157,638 - $276,204
5,858 New
5,858 $164,000
Q1 2022

Jun 20, 2023

SELL
$26.91 - $47.15 $23,357 - $40,926
-868 Reduced 12.91%
5,858 $164,000
Q1 2022

Mar 22, 2023

BUY
$26.91 - $47.15 $57,237 - $100,288
2,127 Added 57.01%
5,858 $164,000
Q1 2022

May 12, 2022

BUY
$26.91 - $47.15 $57,237 - $100,288
2,127 Added 57.01%
5,858 $165,000
Q4 2021

Jun 21, 2023

SELL
$32.97 - $56.85 $98,745 - $170,265
-2,995 Reduced 44.53%
3,731 $171,000
Q3 2021

May 17, 2024

SELL
$26.48 - $35.99 $104,463 - $141,980
-3,945 Reduced 51.39%
3,731 $122,000
Q3 2021

Jun 21, 2023

SELL
$26.48 - $35.99 $79,307 - $107,790
-2,995 Reduced 44.53%
3,731 $122,000
Q3 2021

Mar 22, 2023

SELL
$26.48 - $35.99 $5,666 - $7,701
-214 Reduced 5.42%
3,731 $122,000
Q3 2021

Nov 15, 2021

BUY
$26.48 - $35.99 $98,796 - $134,278
3,731 New
3,731 $122,000
Q1 2021

May 14, 2021

SELL
$28.4 - $36.14 $112,038 - $142,572
-3,945 Closed
0 $0
Q4 2020

Jun 22, 2023

SELL
$23.69 - $31.47 $65,881 - $87,518
-2,781 Reduced 41.35%
3,945 $114,000
Q3 2020

Jun 26, 2023

SELL
$26.38 - $33.1 $73,362 - $92,051
-2,781 Reduced 41.35%
3,945 $111,000
Q2 2020

May 24, 2024

SELL
$29.93 - $50.1 $111,668 - $186,923
-3,731 Reduced 48.61%
3,945 $128 Million
Q2 2020

Jun 26, 2023

SELL
$29.93 - $50.1 $83,235 - $139,328
-2,781 Reduced 41.35%
3,945 $127,000
Q1 2020

Jul 12, 2023

SELL
$30.35 - $67.14 $84,403 - $186,716
-2,781 Reduced 41.35%
3,945 $160,000
Q4 2019

Jul 12, 2023

SELL
$55.65 - $79.83 $154,762 - $222,007
-2,781 Reduced 41.35%
3,945 $243,000
Q3 2019

Jul 12, 2023

SELL
$64.7 - $85.39 $179,930 - $237,469
-2,781 Reduced 41.35%
3,945 $287,000
Q2 2019

Jul 12, 2023

SELL
$67.77 - $82.2 $188,468 - $228,598
-2,781 Reduced 41.35%
3,945 $324,000
Q1 2019

Jul 13, 2023

SELL
$45.83 - $70.54 $127,453 - $196,171
-2,781 Reduced 41.35%
3,945 $278,000
Q4 2018

Jul 13, 2023

SELL
$41.17 - $56.44 $114,493 - $156,959
-2,781 Reduced 41.35%
3,945 $177,000
Q4 2018

Mar 22, 2023

SELL
$41.17 - $56.44 $90,368 - $123,885
-2,195 Reduced 35.75%
3,945 $177,000
Q4 2018

Feb 14, 2019

SELL
$41.17 - $56.44 $90,368 - $123,885
-2,195 Reduced 35.75%
3,945 $178,000
Q3 2018

Jul 13, 2023

SELL
$52.95 - $71.34 $147,253 - $198,396
-2,781 Reduced 41.35%
3,945 $223,000
Q3 2018

Mar 22, 2023

SELL
$52.95 - $71.34 $15,779 - $21,259
-298 Reduced 4.63%
6,140 $347,000
Q3 2018

Nov 14, 2018

BUY
$52.95 - $71.34 $116,225 - $156,591
2,195 Added 55.64%
6,140 $347,000
Q4 2017

Feb 15, 2018

BUY
$53.3 - $74.56 $210,268 - $294,139
3,945
3,945 $254,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $986M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.